PRIMARY STUDY
Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis
Key Findings: This meta-analysis concludes that urinary liver-type fatty acid-binding protein (uL-FABP) could be used as a biomarker for the detection of all stages of diabetic nephropathy and in predicting progression and severity in patients with both type 1 and type 2 diabetes mellitus.
Type of Study: Clinical Meta-analysis
Study Sample Size: 13
Study Result: Positive
Study Location(s): China
Year of Pub: 2022
Cannabinoids Studied: Fatty Acid-Binding Protein (FABP)
Phytocannabinoid Source: Not Applicable
